Navigation Links
Mylan to Acquire Bioniche Pharma Global Injectable Pharmaceuticals Business
Date:7/14/2010

PITTSBURGH, July 14 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced plans to acquire Bioniche Pharma Holdings Limited, a privately held, global injectable pharmaceutical company for $550 million in cash. Bioniche Pharma will provide Mylan not only an immediate entry into the North American injectables market but also a platform for future growth opportunities. This transaction is expected to be accretive to Mylan's earnings in year one, without accounting for any operational or other synergies.

Mylan Chairman and CEO Robert J. Coury said: "We are extremely pleased to be adding this complementary, high growth, high margin business to our one-of-a-kind global pharmaceutical platform. Bioniche Pharma has maintained a long-held strategy of focusing on quality injectable products with limited competition and difficult-to-develop and -manufacture compositions. With this one transaction, we will have acquired the necessary critical mass to compete in the attractive U.S. injectables market as well as the ability to even further leverage this business throughout the rest of our global commercial platform."

In addition, Bioniche Pharma combined with UDL Laboratories, Mylan's unit dose business, will form "Mylan Institutional," a new hospital/institutional business in the North American region of the company's generics segment. This business will focus on the hospital and institutional markets through which Mylan will serve group purchasing organizations, wholesalers, hospitals, surgical and radiology services, home infusion and retail areas with a differentiated and tailored product offering.

Mylan President '/>"/>

SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. RoundTable Healthcare Partners Announces Sale of Bioniche Pharma Holdings Limited to Mylan Inc.
2. Mylan Receives Approval for Nabumetone Tablets
3. Mylan Schedules Second Quarter 2010 Financial Results Conference Call and Live Webcast
4. Mylan Receives Approval for Generic Version of Arimidex® Tablets
5. Mylan Receives Approval for Generic Version of Zocor® Tablets
6. Mylan Receives Approval for Hydroxyzine Hydrochloride Tablets
7. Mylan Receives Approval for Generic Version of Neurontin® Tablets
8. Mylan Receives Approval for Generic Version of Valtrex®
9. Mylan Launches Temazepam Capsules USP, 7.5 mg
10. Mylan Announces Completion of Senior Notes Offering
11. Mylan Announces Upsizing and Pricing of Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2013)... June 20, 2013 Today Moscamed made ... launch of a new programme to control the dengue mosquito ... the State of Bahia. In previous trials Moscamed ... to rapidly reduce the number of dengue mosquitoes in a ... of these mosquitoes were reduced by 96% within 6 months ...
(Date:6/19/2013)... Calif. , June 19, 2013 Pharmacyclics, ... announced that The New England Journal of Medicine ... 2 study evaluating the investigational oral Bruton,s tyrosine kinase ... lymphoma (MCL) online. These data suggested ibrutinib may be ... Results of a separate study examining ...
(Date:6/19/2013)... , June 19, 2013  Haemonetics Corporation ... important developments in the pursuit of its previously ... http://photos.prnewswire.com/prnh/20120206/NE47232LOGO ) , Haemonetics has ... for the future production of medical devices currently ... is a leading global provider of integrated manufacturing ...
Breaking Medicine Technology:Moscamed Launches Urban Scale Project Using Oxitec GM Mosquitoes in Battle Against Dengue 2Moscamed Launches Urban Scale Project Using Oxitec GM Mosquitoes in Battle Against Dengue 3Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 2Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 3Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 4Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 5Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 6Haemonetics Announces Next Steps in Manufacturing Transformation 2Haemonetics Announces Next Steps in Manufacturing Transformation 3Haemonetics Announces Next Steps in Manufacturing Transformation 4
(Date:6/19/2013)... As warmer weather arrives and vacations begin, Asheville’s ... summertime packages. , “Whether guests are traveling to Asheville ... staycation, we think that these available packages will offer ... so beautiful in the summertime and there is a ... can choose from, based on their interests, offers something ...
(Date:6/19/2013)... Across the globe billions of people ... to the medical advances that benefit developed western society. ... care and the necessary aid to help curb the ... Outlook with Ben Kingsley is partnering with ... which these people live and highlight the invaluable resources ...
(Date:6/19/2013)... Researchers from the Icahn School ... studies at ENDO 2013, The Endocrine Society’s Annual ... San Francisco.     , Mount Sinai researchers showed new data ... prostastic acid phosphatase (PAP) in Prostate Cancer (PCa) bone ... gland; revealed the prevalence of primary aldosteronism (PA) in ...
(Date:6/19/2013)... PrettySkin4Less announces it is stocking up ... by top skin care manufacturer EMINENCE to meet customer ... minerals and active organic ingredients to promote actual change ... beauty products offer. For this reason it’s not hard ... "I like products that do what they say they ...
(Date:6/19/2013)... Brain not working? Functional medicine pioneer Datis ... minor brain problems as brain fog, memory loss, fatigue, ... indicate the brain may be degenerating—or aging—too quickly, raising ... and other neurological diseases. Why Isn’t My Brain ... is now available online at Amazon and ...
Breaking Medicine News(10 mins):Health News:Fun Depot Partners with Brookstone Lodge on Summer Packages 2Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 2Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 3Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 4Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 5Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 6Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 7Health News:PrettySkin4Less Launches New Innovative Skin Serums with Active Organic Ingredients to World Wide Consumer Base 2Health News:Brain Not Working? Minor Symptoms Now Could Mean MS, Alzheimer's, or Parkinson's Later 2Health News:Brain Not Working? Minor Symptoms Now Could Mean MS, Alzheimer's, or Parkinson's Later 3
... - To gauge the efficacy of food labels and ... the Vanderbilt University for Health Services //embarked on a ... despite the enduring habit of reading food-labels, as a ... assimilate the information. The pointers that consumers often check ...
... California in Los Angeles reveals that in general, doctors give ... take the medication properly. // ,“This is a good ... patients and doctors,” said the lead author Derjung M. Tarn., ... the journal Archives of Internal Medicine. ,In order ...
... trials of a new vaccine against childhood ear and sinus ... ,According to the researchers, the vaccine will aim at ... that are life saving. ,"We are now in ... better," said Dr. Michael Pichichero, a professor of microbiology, immunology, ...
... The Cape Times has reported that illegal medicines are ... sold on the streets//. The report said many medicines ... the country's health department said the industry had grown ... close down the market because it's too large. So ...
... poll yesterday to see if parents supported the proposal to ... received 1,000 votes in support//. ,"Ofcom has ... junk food advertising would be "disproportionate'," said NHF deputy chief ... bear witness to the widespread and rising concern about the ...
... for the first ultrasound sight of the baby to be born in ... well and the pregnancy is on track. ,This is often ... day of the birth. However this is not enough for an increasing ... a clearer picture of their baby in the womb. ,The ...
Cached Medicine News:Health News:Doctors to give complete information on prescriptions to patients 2Health News:Doctors to give complete information on prescriptions to patients 3Health News:Vaccine for ear and sinus infections to be developed… 2Health News:Peek Before Birth 2
... ORTHOSET Radiopaque Bone Cement consists ... a sterile,ampule containing bone cement ... and a sterile polyethylene bag,containing ... peelable pouch. The interiors of ...
A "doughy" type of bone cement intended for manual application....
... Videoscopes provide superior image quality and ... the camera head with a C-mount ... more light at the operative site ... image clarity and reliability.,The Videoscopes have ...
... OMEGA 180 features a wide range of ... and Variable Pupil Control (U.S. Patent #4,684,227). ... down to 1.2mm. Heine's unique Diffuser aperture ... learning BIO easier, and simplifying difficult examinations. ...
Medicine Products: